ADC Therapeutics Secures $86.6 Million Funding to Bolster Liquidity

Key Facts

1ADC Therapeutics secured $86.6 million in new funding as part of a strategy to bolster its liquidity.

2The financial move includes restructuring the company's existing debt to improve its balance sheet position.

ADC Therapeutics secured $86.6 million in new funding as part of a strategy to bolster its liquidity. Investing.com reported that the financial move includes restructuring the company's existing debt to improve its balance sheet position and support ongoing operations.

ADCT closed at $1.42 on October 7, 2026, with the stock reaching a session high of $1.44 and a low of $1.24. By securing this funding and restructuring its debt, the company aims to reduce immediate financial risks and provide a liquidity cushion.